Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial ([beta]-Blocker Evaluation of Survival Trial [BEST])

MLA

Carson P, et al. “Determination of Hospitalization Type by Investigator Case Report Form or Adjudication Committee in a Large Heart Failure Clinical Trial ([Beta]-Blocker Evaluation of Survival Trial [BEST]).” American Heart Journal, vol. 160, no. 4, Oct. 2010, pp. 649–54. EBSCOhost, https://doi.org/10.1016/j.ahj.2010.07.004.

APA

Carson P, Fiuzat M, O’Connor C, Anand I, Plehn J, Lindenfeld JA, Silver M, White M, Miller A, Davis G, Robertson AD, Bristow M, & Gottlieb S. (2010). Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial ([beta]-Blocker Evaluation of Survival Trial [BEST]). American Heart Journal, 160(4), 649–654. https://doi.org/10.1016/j.ahj.2010.07.004

Chicago

Carson P, Fiuzat M, O’Connor C, Anand I, Plehn J, Lindenfeld JA, Silver M, et al. 2010. “Determination of Hospitalization Type by Investigator Case Report Form or Adjudication Committee in a Large Heart Failure Clinical Trial ([Beta]-Blocker Evaluation of Survival Trial [BEST]).” American Heart Journal 160 (4): 649–54. doi:10.1016/j.ahj.2010.07.004.